Levin_1955_J.Pharmacol.Exp.Ther_113_206

Reference

Title : Inactivation of cholinesterase by compounds related to neostigmine - Levin_1955_J.Pharmacol.Exp.Ther_113_206
Author(s) : Levin AP , Jandorf BJ
Ref : Journal of Pharmacology & Experimental Therapeutics , 113 :206 , 1955
Abstract :

Compounds 3113 CT and 3152 CT, which are chemically related to neostigmine, exhibit an I50(concentration necessary to produce 50 per cent inactivation) against erythrocyte cholinesterase, under specified conditions, of the order of l0-9 M. This figure is contrasted with values reported by Funke et al., namely 10-16 M and 10-14 M, respectively, for the I50 of these two compounds. The inactivation produced by these compounds may be reversed by repeated washing of the erythrocytes. On the basis of current concepts of interaction between cholinesterases and anticholinesterases, and a knowledge of the concentration of active sites in preparations of red blood cells, the figures obtained here are held to reflect more properly the anticholinesterase potency of these agents. Compounds 3113 CT and 3152 CT inactivate red cell cholinesterase more slowly, and are removed less readily by washing procedures, than neostigmine and a parent compound (2842 CT) containing no carbamate groups.

PubMedSearch : Levin_1955_J.Pharmacol.Exp.Ther_113_206
PubMedID: 13234044

Related information

Inhibitor 3152-CT

Citations formats

Levin AP, Jandorf BJ (1955)
Inactivation of cholinesterase by compounds related to neostigmine
Journal of Pharmacology & Experimental Therapeutics 113 :206

Levin AP, Jandorf BJ (1955)
Journal of Pharmacology & Experimental Therapeutics 113 :206